Drawing for SEONIXBIO

USPTO serial 98010136

SEONIXBIO

Reviewed by CopyMark Law Group

Reg. 7583948Status 700Registered
Filing date
Status date
Registration date
Dec 3, 2024
Examiner
MCCLELLAN, MATTHEW D.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SEONIXBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 LEXINGTON AVENUENEW YORK, NY 10174United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for analysing, reporting, screening and tracking data and information for use in the fields of health, medicine, pharmaceutical development, genetics, bioinformatics, ophthalmology, and eye health; downloadable computer software for collecting, analysing, reporting, screening and tracking data and information in the fields of health, medicine, pharmaceutical development, genetics, bioinformatics, ophthalmology, and eye health; downloadable computer software for providing medical or health evaluations; downloadable computer software for providing disease assessment and treatment; downloadable computer software for providing medical or health assessment; downloadable computer software for evaluation and health recommendations based on genetic, genomic, imaging, and clinical data; downloadable computer software for ophthalmological testing or screening; downloadable computer software for glaucoma testing or screeningACTIVE—
042Medical and technological services for research and development services, namely, medical research services and scientific research, analysis, and testing in the field of database development, genetics, biotechnology, bioinformatics, genome studies and health; services for medical research and development in the nature of DNA analysis and screening, genetics, biotechnology, bioinformatics, genome studies and health; research and development services relating to database development, genetics, biotechnology, bioinformatics, genome studies and health; medical research services; scientific research services; scientific analysis services in the field of DNA analysis and bioinformatics, genetics, genome studies and health; laboratory testing services, namely, testing of materials; DNA testing services in the nature of DNA analysis services for scientific research purposes; computer software advisory, development, design and consultancy services; pharmaceutical development services; providing a cloud-based, non-downloadable platform as a service (PAAS) featuring computer software platforms for obtaining, providing and analysing medical and healthcare services; providing a cloud-based, non-downloadable software as a service (SAAS) featuring computer software programs for obtaining, providing and analysing medical and healthcare servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 1, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 23, 2024ALIEASSIGNED TO LIE—
Mar 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2024DOCKASSIGNED TO EXAMINER—
Jun 25, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance